LD-2 disclosure · 4th Quarter - Report
FERRING PHARMACEUTICALS, INC.
via FERRING PHARMACEUTICALS, INC.
Client
- Name
- FERRING PHARMACEUTICALS, INC.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- FERRING PHARMACEUTICALS, INC.
- Description
- pharmaceuticals
- Location
- Parsippany, New Jersey, United States of America
Lobbying activities
1 issueHealth Issues
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
LobbyistsLILLIAN VERNE GERMAN
TargetedSENATE · HOUSE OF REPRESENTATIVES
